Tremor is the most common movement disorders and many patients with tremor continue to live with tremor-related disability. Despite the current technology has created an opportunity for new diagnostic approaches, surgical procedures, and pharmacologic innovations, which hold promise for treatment of tremor, the development of new therapy for tremor is still slow. One of the major obstacles for new therapy development is the lack of a platform for academic researchers, pharmaceutical industries, and funders to unify the research efforts specifically for tremor.

 

To overcome this problem, Drs. Sheng-Han Kuo, Phyllis Faust and Nora Vanegas at Columbia University, Drs. Elan D. Louis at Yale University, Ming-Kai Pan at National Taiwan University come up with the idea to have the 1st International Tremor Congress to promote the collaboration between tremor researchers and between academia and industry. In addition, we want to inspire the next-generation neurologists and neuroscientists to involve in the field of tremor research.